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Background: Several risk scores are available for prognostic purpose in patients presenting with
chest pain.
Aim: The aim of this study was to compare Grace, Pursuit, Thrombolysis in Myocardial Infarction
(TIMI), Goldman, Sanchis, and Florence Prediction Rule (FPR) to exercise electrocardiogram
(ECG), decision making, and outcome in the emergency setting.
Methods: Patients with nondiagnostic ECGs and normal troponins and without history of coronary
disease underwent exercise ECG. Patients with positive testing underwent coronary angiography;
otherwise, they were discharged.
End point was the composite of coronary stenosis at angiography or cardiovascular death,
myocardial infarction, angina, and revascularization at 12-month follow-up.
Results: Of 508 patients considered, 320 had no history of coronary disease: 29 were unable to
perform exercise testing, and finally, 291 were enrolled. Areas under the receiver operating
characteristic curves for Grace, Pursuit, TIMI, Goldman, Sanchis, and FPR were 0.59, 0.68, 0.69,
0.543, 0.66, and 0.74, respectively (P b .05 FPR vs Goldman and Grace). In patients with negative
exercise ECG and overall low risk score, only the FPR effectively succeeded in recognizing those
who achieved the end point; in patients with high risk score, the additional presence of carotid
stenosis and recurrent angina predicted the end point (odds ratio, 12 and 5, respectively). Overall,
logistic regression analysis including exercise ECG, coronary risk factors, and risk scores showed
that exercise ECG was an independent predictor of coronary events (P b .001).
Conclusions: The FPR effectively succeeds in ruling out coronary events in patients categorized
with overall low risk score. Exercise ECG, nonetheless being an independent predictor of coronary
events could be considered questionable in this subset of patients.
© 2012 Published by Elsevier Inc.⁎ Corresponding author. Tel.: +393397472294; fax: +390558947938.
E-mail address: aaaconti@hotmail.com (A. Conti).
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Patients with chest pain (CP) represent a substantial
percentage of visits to the emergency department (ED).
The management of high-risk patients with abnormal
2 A. Conti et al.electrocardiograms (ECGs) and elevated plasma level of
troponin is established [1,2]. However, management is still
questionable in low-risk patients with normal ECGs and
normal troponin. This subset represents a large and
heterogeneous population with low prevalence of coronary
disease [3]: those patients with history of coronary disease
need to be carefully evaluated, whereas those without could
be considered for direct discharge. Moreover, in the
population of patients without history of coronary disease,
diagnostic strategy is costly and time consuming and
represents a continuous challenge for cardiologists and
emergency physicians. Determining which patients need in-
hospital stress testing or outpatient evaluation is still a
dilemma. Thus, effective clinical risk stratification on
admission could move toward the threshold approach to
clinical decision making and save resources [4]. To date,
submitting patients to stress testing is usually based on
nonstandardized clinical judgment [3,5]. Afterwards, several
prediction rules are available for risk stratification in patients
with CP; however, some of these have been tested in
high-risk patients [6-10], whereas others, in low-risk patients
[11-13]. In addition, some prediction rules are based on
clinical data, whereas others used only major risk factors
for atherosclerosis [14-16]. Therefore, which risk score to be
used remains a challenge because no standardized prediction
rule is yet available for stratification of patients with low-risk
CP [3,17-19].
The objective of this study was to characterize a cohort of
patients with CP presenting to the ED with risk scores
calculated by Grace, Pursuit, TIMI, Goldman, Sanchis, and
Florence Prediction Rules (FPRs) [6-9,11-13] and compare
the scores to outcomes.2. Methods
2.1. Patient selection
All consecutive adult patients with CPwho presented to the
ED of the tertiary care teaching Careggi Hospital were
evaluated during the years 2008 and 2009. Patients with
abnormal ECGs or positive troponin and patients with history
of coronary disease or severe comorbidities or a life expectancy
less than 6 months were excluded from the study. Patients with
atypical CP were also excluded from the study. Tourists
and inhabitants outside the catchment area of Careggi
University Hospital serving a population of half a million
were not enrolled in the study. All patients gave their consent
for study participation. The study was conducted according
to good clinical practice and the Declaration of Helsinki.
2.2. Management of patients and study protocol
All patients underwent a first-line, 6-hour workup
including clinical evaluation, serial ECGs, and serialtroponins [2,3,17-19]. Enrolled patients with CP were
categorized by all the previously validated risk scores
(Grace, Pursuit, TIMI, Goldman, Sanchis, and FPR) [6-13].
Patients were characterized also by the presence of coronary
risk factors such as diabetes, metabolic syndrome, hyperten-
sion, high blood cholesterol, familial history of coronary
disease, and current smoking. During the time of triage to
the ED, a research nurse detects vital signs on admission
(systolic and diastolic blood pressure, heart rate, oxygen
saturation, and breaths per minute) and prospectively records
variables used to calculate the scores for the risk stratifica-
tion. During the visit, the resident checks the correctness of
the findings and integrates them with information obtained
from patients, relatives, caregivers, and previous hospital
freely accessed folders available on the hospital network. To
avoid overestimation of coronary risk profile, when
information regarding some risk factors were unavailable,
we assumed that the patient did not have that risk factor.
Diagnosis of diabetes was based on history or presence of
fasting glucose greater than 125 mg/dL in at least 2 mea-
surements or current hypoglycemic drug therapy. Diagnosis
of metabolic syndrome consisted of history or presence of 3
or more of the following: high fasting glucose (N110 mg/dL),
high blood pressure (systolic blood pressure N130 mm Hg
and diastolic blood pressure N85 mm Hg), low high-density
lipoprotein cholesterol (b40 mg/dL in men and b50 mg/dL in
women), high triglycerides (N150 mg/dL), and central
obesity (waist circumference N102 cm in men and N88 cm
in women) [14-16]. Based on self-reported cholesterol levels,
weights, and heights, mean total blood cholesterol levels of
200 mg/dL or higher were considered abnormal as is the
presence of body mass index of 3.0 kg/m2 and higher.
Resting echocardiography was performed in all patients [17].
Unstable angina and acute myocardial infarction were
defined according to international guidelines [1,2,20].
During observation in the ED, patients showing ischemic
ECG changes and/or abnormal troponin levels and/or wall
motion abnormalities at echocardiography were considered
at high risk for coronary events; thus, they were referred for
urgent coronary angiography [3,20].
Patients with typical CP and without history of coronary
disease were considered at low risk and were submitted to
early in-hospital exercise ECG by nonstandardized clinical
judgment [3,5,17,21]. Patients with positive testing were
considered at high risk for coronary events; they were
admitted and referred for early coronary angiography.
Conversely, patients with negative testing were considered
at very low risk; they were discharged and followed up.
2.3. Characterization of patients by the risk scores
All patients with normal ECGs and normal troponins
were considered at low risk for coronary events. They
were categorized by all available risk scores: Grace,
Pursuit, TIMI, Goldman, Sanchis, and FPR. Patients with
at least very low scores (eg, Grace b96, Pursuit b5, TIMI b3,
Table 1 Clinical CP score
Location Score
Substernal, precordial +3
Left chest, neck, lower jaw, epigastrium +1
Apex −1
Radiation
Either arm, shoulder, back, neck, lower jaw +1
Character
Crushing, pressing, heaviness +3
Sticking, pleuritic, pinprick −1
Associated symptoms
Dyspnea, nausea, diaphoresis +2
3Risk scores and chest painGoldman b2, Sanchis b2, and FPR b2) were considered as
having a very low risk of future coronary events, whereas the
remaining patients were considered as having a substantial
risk of coronary events.
The novel FPR is a simple score strictly based on few
clinical characteristics on presentation: CP score greater than
6, male sex, age 50 years or older, diabetes, or metabolic
syndrome (Tables 1 and 2) [6-13].
2.4. Follow-up
All the enrolled patients were submitted to follow-up.
Follow-up data were gathered with telephone interviews at 1
and 12 months by residents, and all events were analyzed by
review of hospital records and laboratory data.
2.5. End point
End point was the composite of coronary stenosis at
angiography or cardiovascular death, myocardial infarction,
angina, and revascularization at follow-up.
2.6. Statistics analysis
Continuous variables were reported as mean ± standard
deviation. Frequencies were shown as percentages and
absolute values. Predictors of coronary event were analyzed
with the logistic regression analysis by backward stepwise
(likelihood ratio). Sensitivity and specificity of each
prognostic score were evaluated by receiver operating
characteristic (ROC) curves; the areas under the ROC curvesTable 2 The FPR
CP score N6 +3
Age N50 y +1
Male sex +1
DM or MS +1
DM indicates diabetes mellitus; MS, metabolic syndrome.were compared by the analysis of variance for summary data
test. Continuous variables were compared through 1-way
analysis of variance and t test, whereas percentages were
compared with χ2 or Fisher exact test when expected
frequencies were less than 5%. Two-tailed P b .05 was
considered statistically significant. Statistical analysis were
performed using SPSS Package, version 17 (SPSS Inc,
Chicago, IL).3. Results
3.1. Patients screened for the study
During the years 2008 to 2009, 508 patients with CP
presenting nondiagnostic ECG were considered for enroll-
ment. They underwent stress testing after the first-line
evaluation inside the ED including serial ECGs and serial
troponins. Of these, 320 patients (63%) had no history of
coronary disease and fulfilled the inclusion criteria. Twenty-
nine patients (9%) were unable to perform exercise ECG and
were submitted to stress radionuclide myocardial perfusion
imaging or stress echocardiography. Thus, 291 patients with
nondiagnostic ECGs and normal troponins and without
previous history of coronary disease were enrolled and
underwent exercise ECG. No patient was lost to follow-up.
3.2. Study population
Baseline clinical characteristics of enrolled patients are
reported in Table 3. Of 291 patients enrolled, 23 (8%) had
positive exercise ECG, and 14 of these (61%) had coronary
stenoses 50% or greater at angiography. Of these, those
who presented occlusive coronary stenosis (ie, stenosis
N70%, n = 7) underwent percutaneous transluminal coronary
angioplasty, and 1 more patient underwent coronary artery
bypass graft. The remaining 268 patients (92%) had negative
testing, and 14 (5%) of these reached the end point during
the 9.9 ± 4.9 months of follow-up. Of these, no patient
was lost to follow-up. Thus, in our population, overall
negative predictive value of exercise ECG in ruling out
coronary events was 95%, and diagnostic accuracy was 92%.
3.3. Comparison of risk scores and outcomes
For each risk score, event rate increased as the prediction
rule increased. The areas under the ROC curves for Grace,
Pursuit, TIMI, Goldman, Sanchis, and FPR were 0.589,
0.683, 0.694, 0.536, 0.663, and 0.740, respectively (P b .05
FPR vs Goldman and Grace, Fig. 1). Of note, the areas under
the ROC curves of the FPR and exercise ECG were similar
(0.740 vs 0.733, respectively; P = .93) (Fig. 2). Among
prognostic scores, FPR was the best, but results did not
reach statistical significance (P = .56). In patients with very
Table 3 Baseline clinical characteristics and outcomes in patients with CP, negative first-line workup, and unknown coronary disease
enrolled in the study and submitted to exercise ECG (n = 291)
Total (n = 291) FPR 0-1 (n = 89) FPR 2-6 (n = 202) P
Age (y) 61 ± 12 57 ± 13 62 ± 11 .0004
Female sex 64 (22%) 58 (65%) 51 (25%) b.0001
Hypertension 146 (50%) 45 (51%) 101 (50%) .004
DM 25 (9%) 0 (0%) 25 (12%) b.0001
Smoker 67 (23%) 19 (21%) 48 (24%) .66
Hyperlipidemia 64 (22%) 15 (17%) 49 (24%) .23
Obesity 14 (5%) 3 (3%) 11 (5%) b.0001
Familiarity of coronary disease 46 (16%) 15 (17%) 31 (15%) .23
CP episodes N1 within previous 24 h 16 (5%) 1 (1%) 15 (7%) b.0001
CP score 6.1 ± 2.2 4.6 ± 1.3 6.7 ± 2.2 b.0001
End point 28 (10%) 2 (2%) 26 (13%) b.0001
End point: coronary stenosis at angiography or cardiovascular death, myocardial infarction, revascularization, and angina at follow-up.
4 A. Conti et al.low score, considered at very low risk (n = 89, FPR 0-1, 1%
expected coronary events), the exercise ECG was negative in
1 of the 2 patients with coronary event at follow-up, and
ruling out accounts for 99%. Conversely, analyzing the
remaining subset of patient with higher score, considered at
substantial risk (n = 202, FPR 2-6, 4%-25% expected
coronary events), exercise ECG missed the diagnosis in 13
patients, and ruling out accounts for 94% (P = .003).
Interestingly, in very low-risk patients, ruling out coronary
disease by exercise tolerance test was comparable with
FPR (99% vs 98%, respectively; P, not significant). How-
ever, at the logistic regression analysis model including
exercise ECG, coronary risk factors, and risk scores, only
exercise ECG was an independent predictor of coronary
events (P b .001).1,0
0,8
0,6
0,4
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1,00,80,60,40,2
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Fig. 1 Areas under the ROC curves of FPR (0.740), Goldman
(0.536); Grace (0.589); Pursuit (0.683); Sanchis (0.663); TIMI
(0.694); P b .05 vs Goldman and Grace.3.4. Exploring the potential clinical impact of
scores in patients with negative exercise ECG
When patients with negative exercise ECG were evalu-
ated according to the presence of very low score (eg, FPR b2,
Sanchis b2, TIMI b3, and PURSUIT b5), only 1 patient with
negative exercise ECG reached the end point; in this patient,
no clinical predictors were available. However, in this subset
of patients, FPR effectively succeeded in recognizing
patients who achieved the end point, and FPR was superior
to other scores (Table 4). Conversely, in patients with higher
score (FPR ≥2, Sanchis ≥2, TIMI N2, and PURSUIT ≥5),
13 reached the end point. In this subset of patients, carotid
stenosis (odds ratio [OR], 12.3; 95% confidence interval
[CI], 1.9-79.5) and recurrent angina (ie, N1 episode of CP1,0
0,8
0,6
0,4
0,2
1,00,80,60,40,2
0,0
0,0
Excercise Tolerance Test
Florence Prediction Rule
ig. 2 Areas under the ROC curves of the FPR (0.740) andF
exercise tolerance test (0.733); P = .93.
Table 4 Power of prognostic scores (FPR b2, Sanchis b2,
TIMI b3, and Pursuit b5) in separate patients at low risk from
those at high risk in a population presenting CP and negative
exercise ECG
FPR Sanchis TIMI PURSUIT
Low risk 1 (1.2%) 11 (4.9%) 11 (4.6%) 0 (0%)
Pearson χ2 P = .040 P = .633 P = .236 P = .059
High risk 13 (7.1%) 3 (6.7%) 3 (9.7%) 14 (6.5%)
5Risk scores and chest painwithin previous 24 hours; OR, 4.5; 95% CI, 1.4-14.6) were
independent predictors of coronary events (Table 5).
3.5. Patients submitted to other stress testing
Of the 29 patients unable to perform the exercise tolerance
test, 5 with poor echocardiographic window underwent
single photon emission computed tomography with pharma-
cologic stress (adenosine) (2 patients had positive test result,
1 of which was without events at follow-up; 3 patients had
negative test result, and all without events at follow-up),
whereas 24 patients were studied with pharmacologic stress
(dobutamine) echocardiography (6 patients had positive
test result, 1 of which was without events at follow-up; 18
patients had negative test result, only 1 of which was with
event at follow-up). Overall, in this cohort, the negative
predictive value was 95%, and positive predictive value
was 75%.4. Discussion
The present study analyzed the impact of clinical
application of all the available risk scores as Grace, Pursuit,
TIMI, Goldman, Sanchis, and the FPR [6-13] in a cohort of
291 patients with CP with negative first-line workup and
without known coronary disease. These patients were usually
labeled as low-risk patients, and they eventually showed
coronary events up to 20% [3,5,17,21]. All scores effectively
stratified the cardiovascular risk of patients with CP;
however, which risk score could be used in the ED to
improve time consuming and costly management remainedTable 5 Risk of coronary event in patients with negative
exercise ECG and different clinical characteristics
Parameter Coronary
event (OR)
95% CI
Carotid stenosis 12.3 1.9-79.5
CP episode N1 within previous 24 h 4.5 1.4-14.6
DM 0.71 0.1-3.4
Male sex 0.70 0.3-1.8to be stated. Moreover, who of the low-risk patients with
CP without history of coronary disease need stress testing
or can be discharged and followed up as outpatient is still
a dilemma.
Results of present study showed that the novel FPR, a
simple score strictly based on few clinical characteristics on
presentation (CP score N6, male sex, age ≥50 years,
diabetes, or metabolic syndrome), was more accurate than
others in stratifying the risk of coronary events in patients
with CP (Fig. 1). Areas under the ROC curves for Grace,
Pursuit, TIMI, Goldman, Sanchis, and FPR were 0.59, 0.68,
0.69, 0.543, 0.66, and 0.74, respectively (P b .05 FPR vs
Goldman and Grace). In patients with negative exercise ECG
and overall low risk score, only the FPR effectively
succeeded in recognizing those who achieved the end
point; in patients with high risk score, the additional
presence of carotid stenosis and recurrent angina predicted
the end point (OR, 12 and 5, respectively). Nonetheless, the
areas under the ROC curves of the FPR and exercise ECG
were similar (0.740 vs 0.733, respectively; P = .93); only
exercise ECG was recognized as an independent predictor of
coronary event at logistic regression analysis (P b .001).
Thus, exercise ECG remains to be the first-line stress testing
in these patients with CP. However, ruling out coronary
events by FPR accounted for 98% in patients with score 0 to
1 as compared with 99% of exercise ECG. This fact could
represent an attractive option for CP screening in the ED of
the crowded public health care delivery system; indeed, very
low-risk patients account for one third of patients with CP in
our series. In patients with negative exercise ECG, the FPR
low score effectively succeeded in separating those at low
from those at high risk (Table 4). Higher score eventually
showed additional risk of coronary events if presenting
carotid stenosis or recurrent angina (Table 5).
Thus, the hypothetical threshold approach to decision
making in patients with CP matched with data of present
study suggests that patients with typical CP need first-line
screening by exercise ECG.When this testing is negative and
the FPR is 0 to 1, patients could be safely discharged;
conversely, when the FPR is 2 to 6, patients could be
considered for additional stress testing, having a higher risk
of coronary event. However, only patients presenting carotid
stenosis or recurrent angina could be considered for the
second-line costly in-hospital stress imaging. Eventually,
these patients, having a risk of coronary event up to 15%,
could be directly submitted to angiography.
4.1. Strengths of present study
(1) To our knowledge, this is the first study in which
patients with CP and initial negative workup were catego-
rized with all the available risk scores of coronary events; (2)
in patients without history of coronary disease, the novel
FPR easily applicable in clinical practice seems to offer the
best prognostication as compared with other risk score; (3)
when FPR is low, exercise ECG prognostic yield may be
Fig. 3 Goldman algorithm. Four groups into which patients can be categorized according to risk of major cardiac events within 72 hours
after admission.
6 A. Conti et al.questionable. Thus, these patients could be early discharged
and eventually evaluated as outpatient economizing on in-
hospital stress testing. (4) The remaining patients with higher
score could be likely considered for early exercise ECG, and
patients with negative testing eventually could be catego-
rized as high-risk patients when presenting carotid stenosis
or recent recurrent angina.
Previously multivariate algorithms have been developed
in patients presenting CP to the ED. The management of35
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luminal coronary angioplasty.high-risk patients including diagnostic ECGs and elevated
plasma level of troponin is well established [6-9]; however,
the management of low-risk patients with nondiagnostic
serial ECGs and troponins is questionable. Indeed, low-risk
patients represented a large and heterogeneous population
with a low prevalence of coronary disease, and they
presented different cardiovascular risk factors and clinical
pattern and finally showed different outcomes. In this subset
of patients, some risk scores allowed estimation for the need
of intensive care [22,23]. Other models of risk scores well
stratified the overall population of patients with CP [24,25];
however, they could not be easily integrated in clinical
practice because of their complexity [24,25]. Other risk
scores are specific in the prognostic evaluation of patients
with a definite acute coronary syndrome [6-10,23]. The
simplicity of the novel FPR is caused by the few variables
considered and to the relevance given to clinical character-
istics of CP at presentation. Indeed, the presence of high CP
score has a high factor in cumulated risk score [13]. Patients
with FPR low score showed a very low probability of future
coronary events, less than 1%, data which are even lower
than the risk reported in low-risk patients considered in
previous studies [3,19].5. Limits of the study
Results of present study were derived from patients
presenting to our tertiary care teaching hospital and need
validation in other centers. Moreover, the results in this
cohort of patients are not extensible to symptomatic general
population because of the exclusion of patients with
prior diagnosis of coronary artery disease, resting echo-
cardiography left ventricular dysfunction, or wall motion
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7Risk scores and chest painabnormalities. In addition, the outcome evaluation based on
dichotomy (normal/abnormal tests) may be a limitation of
any screening workup in patients with CP. Finally, theFig. 6 Pursuit score. The 1-month and 1-year end point in the differen
from the initial clinical history, ECG, and laboratory values collected on
MACE 10%.optimal use of exercise ECG in patients with CP needs to be
confirmed in a properly designed study beyond the
preliminary results of this analysis.30
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9Risk scores and chest pain6. Conclusions
Florence Prediction Rule accurately predicts the risk of
coronary events in patients with CP and nondiagnostic ECG,
without existing known coronary disease, and may be a
valuable tool for guiding management by threshold approach
to clinical decision making. In these patients, FPR showed
the best prognostication as compared with the other available
risk scores such as Grace, Pursuit, TIMI, Goldman, and
Sanchis. Overall, exercise ECG added prognostic value to
the FPR, but its role was questionable in the subset of
patients with very low score. In these patients, both exercise
ECG and the FPR showed the same power in ruling out
coronary events. Finally, in our series, patients with higher
score and negative exercise ECG need additional stress
imaging when presented carotid stenosis or recurrent angina,
which were recognized as predictors of coronary events.Appendix A. The scoring for the decision rules
Updated available risk scores in patients with CP are listed
below, and Figs. 3 to 8 show the various scoring system. The
risk scores that should be used as a tool for risk stratification
and decision making on admission of patients with CP with
nondiagnostic ECG and troponin in the ED are Goldman
algorithm, Sanchis Score, FPR, TIMI risk score, Pursuit score,
and Grace score [6-13]. They use clinical information as well
as findings on an ECG to determine a percentage likelihood
that a given patient is likely having aMajor Adverse Coronary
Event (MACE). These tools are more sensitive and more
specific than clinicians for predicting MACE. However, these
tools do not replace clinical judgment but serve as an aid in
decision making. In the present study, patients with low-risk
profile of future cardiac events were enrolled and stratified
with all the aforementioned risk scores.References
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